Just in: This paper provides New Insights for Obesity Treatment

We all know that obesity disrupts the adaptability of adipose tissue, impairing its ability to regulate energy and metabolism. Recent research published in Cell Reports¹ sheds light on how PPARγ agonists, like rosiglitazone, could help restore this adaptability by reprogramming adipose progenitors.